A Study to Investigate the Effect of Mitapivat on Transfusion Burden in Subjects With Sickle Cell Disease (SCD)
Clinical trial NCT07656415 · RECRUITING
Trial details
- NCT number
- NCT07656415
- Sponsor
- Agios Pharmaceuticals, Inc.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-21
- Primary completion
- 2029-08-01
- Enrollment
- 159
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.